Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID Reference, 4th edition, 372 pages + the daily Top 10

Ovarian Neoplasms

Free Subscription 27.07.2020 1 BMC Cancer 1 Cancer 3 Gynecol Oncol 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Cancer

1. LI T, Wang J
   Therapeutic effect of dual CAR-T targeting PDL1 and MUC16 antigens on ovarian cancer cells in mice.
   BMC Cancer. 2020;20:678.
   PubMed         Abstract available
   
   

   
   Cancer

2. CORR BR, Moroney M, Sheeder J, Eckhardt SG, et al
   Survival and clinical outcomes of patients with ovarian cancer who were treated on phase 1 clinical trials.
   Cancer. 2020 Jul 22. doi: 10.1002/cncr.33073.
   PubMed         Abstract available
   
   

   
   Gynecol Oncol

3. TAYLAN E, Zayou F, Murali R, Karlan BY, et al
   Dual targeting of GSK3B and HDACs reduces tumor growth and improves survival in an ovarian cancer mouse model.
   Gynecol Oncol. 2020 Jul 19. pii: S0090-8258(20)32380.
   PubMed         Abstract available
   
   
4. WU JL, Zhao J, Zhang HB, Zuo WW, et al
   Genetic variants and expression of the TIM-3 gene are associated with clinical prognosis in patients with epithelial ovarian cancer.
   Gynecol Oncol. 2020 Jul 18. pii: S0090-8258(20)32387.
   PubMed         Abstract available
   
   
5. ZHENG L, Cui C, Shi O, Lu X, et al
   Incidence and mortality of ovarian cancer at the global, regional, and national levels, 1990-2017.
   Gynecol Oncol. 2020 Jul 18. pii: S0090-8258(20)32383.
   PubMed         Abstract available
   
   

   
   PLoS One

6. PYEON SY, Han GH, Ki KD, Lee KB, et al
   Effect of delayed palliative chemotherapy on survival of patients with recurrent ovarian cancer.
   PLoS One. 2020;15:e0236244.
   PubMed         Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: